DECIPHERA PHARMACEUTICALS

deciphera-pharmaceuticals-logo

Deciphera is a biopharmaceutical company focused on discovering, developing, and commercializing important new medicines to improve the lives of people with cancer. We are leveraging our proprietary switch-control kinase inhibitor platform and deep expertise in kinase biology to develop a broad portfolio of innovative medicines. In addition to advancing multiple product candidates from our platform in clinical studies, QINLOCK® is Deciphera’s switch control inhibitor for the treatment of fourth-line GIST. QINLOCK is approved in Australia, Canada, China, the European Union, Hong Kong, Switzerland, Taiwan, the United Kingdom, and the United States.

#SimilarOrganizations #People #Financial #Website #More

DECIPHERA PHARMACEUTICALS

Social Links:

Industry:
Biotechnology Health Care Medical Pharmaceutical Therapeutics

Founded:
2003-01-01

Address:
Waltham, Massachusetts, United States

Country:
United States

Website Url:
http://www.deciphera.com

Total Employee:
251+

Status:
Active

Contact:
(781) 209-6400

Email Addresses:
[email protected]

Total Funding:
886.5 M USD

Technology used in webpage:
Amazon Google Maps JsDelivr COVID-19 Amazon Virginia Region CloudFront Amazon S3 Ruby On Rails Token Microsoft OSS CDN


Similar Organizations

3z-pharmaceuticals-logo

3Z Pharmaceuticals

3Z Pharmaceuticals focuses on developing drugs that would improve the central nervous system.

actinium-pharmaceuticals-logo

Actinium Pharmaceuticals

Actinium Pharmaceuticals develops alpha particle linked antibodies to treat cancer.

amylyx-pharmaceuticals-logo

Amylyx Pharmaceuticals

Amylyx Pharmaceuticals specializes in providing solutions for Alzheimer’s and other diseases of the brain.

apellis-pharmaceuticals-logo

Apellis Pharmaceuticals

Apellis Pharmaceuticals focuses on developing novel therapeutics and drug delivery technologies to address chronic inflammatory diseases.

aveo-oncology-logo

AVEO Oncology

AVEO is a biopharmaceutical company that offers drug development strategies for targeted cancer therapeutics.

biodelivery-sciences-logo

BioDelivery Sciences

BioDelivery Sciences is a pharmaceutical company that focuses on pain management and addiction medicine.

elicio-therapeutics-logo

Elicio Therapeutics

Elicio Therapeutics develops an immuno-tumor vaccine to treat cancer.

pacylex-logo

Pacylex

Pacylex Pharmaceuticals develops a precision medicine solution for multiple common cancers.

salix-pharmaceuticals-logo

Salix Pharmaceuticals

Salix Pharmaceuticals is a specialty pharmaceutical company focused on the prevention and treatment of gastrointestinal disorders.

stipe-therapeutics-logo

STipe Therapeutics

STipe Therapeutics focuses on harnessing the innate immune system to battle cancer.

torigen-pharmaceuticals-logo

Torigen Pharmaceuticals

Torigen Pharmaceuticals focuses on providing cancer care solutions for animals.

vetsource-logo

VetSource

VetSource is a pharmaceuticals company providing pet care medication and vaccination services.

x4-pharmaceuticals-logo

X4 Pharmaceuticals

X4 Pharmaceuticals a clinical-stage oncology company developing best-in-class oral small molecule CXCR4 antagonists for the treatment.


Current Advisors List

michael-ross_image

Michael Ross Board of Directors @ Deciphera Pharmaceuticals
Board_member

ron-squarer_image

Ron Squarer Member Board Of Directors @ Deciphera Pharmaceuticals
Board_member
2019-12-01

liam-ratcliffe_image

Liam Ratcliffe Board Member @ Deciphera Pharmaceuticals
Board_member

patricia-allen_image

Patricia Allen Board Member and Audit Committee Chair @ Deciphera Pharmaceuticals
Board_member
2016-09-01

patrick-oconnor_image

Patrick O’Connor Scientific Advisory Boards @ Deciphera Pharmaceuticals
Advisor

Current Employees Featured

steven-l-hoerter_image

Steven L. Hoerter
Steven L. Hoerter President and CEO @ Deciphera Pharmaceuticals
President and CEO
2019-03-01

steve-ruddy_image

Steve Ruddy
Steve Ruddy CTO @ Deciphera Pharmaceuticals
CTO
2018-05-01

chris-morl_image

Chris Morl
Chris Morl CBO @ Deciphera Pharmaceuticals
CBO
2016-10-01

matthew-l-sherman_image

Matthew L. Sherman
Matthew L. Sherman EVP & CMO @ Deciphera Pharmaceuticals
EVP & CMO

tucker-p-kelly_image

Tucker P. Kelly
Tucker P. Kelly EVP & Chief Financial Officer @ Deciphera Pharmaceuticals
EVP & Chief Financial Officer
2015-02-01

Founder


michael-d-taylor_image

Michael D. Taylor

Stock Details


Company's stock symbol is NASDAQ:DCPH

Investors List

viking-global-investors_image

Viking Global Investors

Viking Global Investors investment in Series C - Deciphera Pharmaceuticals

sphera-global-health-care-fund_image

Sphera Global Healthcare Fund

Sphera Global Healthcare Fund investment in Series C - Deciphera Pharmaceuticals

redmile-group_image

Redmile Group

Redmile Group investment in Series C - Deciphera Pharmaceuticals

new-leaf-venture-partners_image

New Leaf Venture Partners

New Leaf Venture Partners investment in Series C - Deciphera Pharmaceuticals

sv-life-sciences_image

SV Health Investors

SV Health Investors investment in Series B - Deciphera Pharmaceuticals

new-leaf-venture-partners_image

New Leaf Venture Partners

New Leaf Venture Partners investment in Series B - Deciphera Pharmaceuticals

Official Site Inspections

http://www.deciphera.com Semrush global rank: 3.9 M Semrush visits lastest month: 3.26 K

  • Host name: 23.185.0.1
  • IP address: 23.185.0.1
  • Location: United States
  • Latitude: 37.751
  • Longitude: -97.822
  • Timezone: America/Chicago

Loading ...

More informations about "Deciphera Pharmaceuticals" on Search Engine